Although patient selection is critical, TORS offers a minimally invasive option to access oropharyngeal tumors through the mouth.
Dermatologic complications are common in lung transplant recipients, and early treatment for suspicious lesions is crucial in this population. Learn more about five different types of cutaneous complications.
The phase 3 KEYNOTE-630 trial has begun enrolling patients with high-risk, locally advanced cutaneous squamous cell carcinoma (cSCC) to evaluate the curative potential of PD-1 inhibitor pembrolizumab.
As lung transplants become more common, clinicians should be aware of post-transplant dermatologic complications including squamous cell carcinoma.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
An increasing share of oropharyngeal cancers are due to HPV infection, which is translating to better treatment response. And emerging findings suggest a bacterial connection with oral cancers.